From the Max Delbrück Center for Molecular Medicine via ScienceDaily: The presence of specific autoantibodies of the immune system is associated with blood vessel damage in the brain. These findings were made by Marion Bimmler,…
From the Monash University press release: Neuroscientists have discovered a new area of the brain that is uniquely specialised for peripheral vision and could be targeted in future treatments for panic disorders and Alzheimer’s disease.…
From the University of Kentucky press release via EurekAlert!: In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University…
From the Northwestern University press release via EurekAlert!: A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer’s disease, Parkinson’s disease, multiple…
From the Peninsula College of Medicine and Dentistry via EurekAlert!: Researchers from the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, will present the findings of a new study suggesting a link between…
From the American Academy of Neurology press release via EurekAlert!: Higher levels of a certain fat in the blood called ceramides may increase a person’s risk of developing Alzheimer’s disease, according to a study published…
From the University of Wisconsin-Madison press release via EurekAlert!: Metabolic syndrome, a term used to describe a combination of risk factors that often lead to heart disease and type 2 diabetes, seems to be linked…
From the University of Medicine and Dentistry of New Jersey press release via ScienceDaily: Researchers from the University of Medicine and Dentistry of New Jersey (UMDNJ), collaborating with scientists from Northwestern University in Illinois, have…
From the University of Pennsylvania School of Medicine press release via EurekAlert!: While clinical trial results are being released regarding drugs intended to decrease amyloid production – thought to contribute to decline in Alzheimer’s disease…
From the Mayo Clinic press release via ScienceDaily: Activity lingers longer in certain areas of the brain in those with Alzheimer’s than it does in healthy people, Mayo Clinic researchers who created a map of…